Correlation Between Enliven Therapeutics and Reviva Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Enliven Therapeutics and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Reviva Pharmaceuticals.
Diversification Opportunities for Enliven Therapeutics and Reviva Pharmaceuticals
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Enliven and Reviva is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Reviva Pharmaceuticals go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Reviva Pharmaceuticals
Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 0.56 times more return on investment than Reviva Pharmaceuticals. However, Enliven Therapeutics is 1.79 times less risky than Reviva Pharmaceuticals. It trades about -0.03 of its potential returns per unit of risk. Reviva Pharmaceuticals Holdings is currently generating about -0.27 per unit of risk. If you would invest 2,127 in Enliven Therapeutics on December 1, 2024 and sell it today you would lose (44.00) from holding Enliven Therapeutics or give up 2.07% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. Reviva Pharmaceuticals Holding
Performance |
| Timeline |
| Enliven Therapeutics |
| Reviva Pharmaceuticals |
Enliven Therapeutics and Reviva Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and Reviva Pharmaceuticals
The main advantage of trading using opposite Enliven Therapeutics and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.| Enliven Therapeutics vs. Pmv Pharmaceuticals | Enliven Therapeutics vs. Cullinan Oncology LLC | Enliven Therapeutics vs. Immuneering Corp | Enliven Therapeutics vs. Aerovate Therapeutics |
| Reviva Pharmaceuticals vs. Protalix Biotherapeutics | Reviva Pharmaceuticals vs. Eyepoint Pharmaceuticals | Reviva Pharmaceuticals vs. Sellas Life Sciences | Reviva Pharmaceuticals vs. In8bio Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |